CORTICOBASAL SYNDROME (CBS)
Clinical trials for CORTICOBASAL SYNDROME (CBS) explained in plain language.
Never miss a new study
Get alerted when new CORTICOBASAL SYNDROME (CBS) trials appear
Sign up with your email to follow new studies for CORTICOBASAL SYNDROME (CBS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a liver drug slow a rare brain disease?
Disease control OngoingThis study tests whether glycerol phenylbutyrate (GPB) can slow corticobasal syndrome (CBS), a rare and fast-progressing brain disease. About 32 adults with CBS will receive GPB or a placebo for 26 weeks. The main goal is to see if GPB lowers a marker of nerve damage called NfL i…
Matched conditions: CORTICOBASAL SYNDROME (CBS)
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
New study probes brain inflammation in rare dementia forms
Knowledge-focused OngoingThis study looks at how inflammation in the brain affects people with frontotemporal lobar degeneration (FTLD), a group of rare dementias. Researchers will use advanced MRI scans, blood tests, and spinal fluid samples from 110 participants to track markers of inflammation and ner…
Matched conditions: CORTICOBASAL SYNDROME (CBS)
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC